| Dr Amy Dinh Shepard, PHARM D | |
|
416 W Olive Ave, Porterville, CA 93257-3332 | |
| (559) 791-0104 | |
| Not Available |
| Full Name | Dr Amy Dinh Shepard |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 416 W Olive Ave, Porterville, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306126875 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 64841 (California) | Primary |
| 183500000X | Pharmacist | RPH-0012620 (Oregon) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Amy Dinh Shepard, PHARM D 416 W Olive Ave, Porterville, CA 93257-3332 Ph: (559) 791-0104 | Dr Amy Dinh Shepard, PHARM D 416 W Olive Ave, Porterville, CA 93257-3332 Ph: (559) 791-0104 |
News Archive
DynaVox Inc., a leading provider of software, devices and content to assist people in overcoming their speech, language or learning disabilities, announced today that its initial public offering of 9,375,000 shares of its Class A common stock has been priced at $15.00 per share. The shares are expected to begin trading tomorrow, April 22, 2010, on the NASDAQ Global Select Market under the ticker symbol "DVOX."
HIV-positive women across Africa are facing discrimination, with many "say[ing] they have been pressured – even forced – not to have children because people assume they will infect their babies," PRI's The World reports. "Across the continent, there have been organized efforts to prevent HIV-positive women from having children," The World writes, referencing family planning programs aimed at HIV-positive women in Kenya, Namibia and Uganda.
Obesity and overweight affect more than half of the population in our Community. Excess weight causes important alterations in the organism, one of which affects liver function. Fat accumulates in the liver producing hepatic steatosis which, in certain circumstances, causes inflammation, fibrosis and finally, cirrhosis.
World Heart Corporation (WorldHeart) announced today that it has finalized assignment and exclusive license agreements with LaunchPoint Technologies Inc., (LPT) Goleta, California, and Carnegie Mellon University (CMU), Pittsburgh, Pennsylvania for its next-generation minimally invasive blood pump, the MiVAD. The MiVAD(TM) is designed to provide partial cardiac support between 2-4 liters per minute to less sick heart failure patients than those served by existing full-support Left Ventricular Assist Devices (LVADs).
By comparing vaccination rates in 580 counties across the United States with the corresponding coronavirus disease (COVID-19) incidence rates, a recent study currently available on the medRxiv preprint server finds that cumulative county-level vaccination rates are significantly associated with a concomitant fall in the incidence of COVID-19.
› Verified 2 days ago
Lauren Skorheim, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 26501 Avenue 140, Porterville, CA 93257 Phone: 559-782-2222 | |
Lana Thao Nguyen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 66 W Morton Ave, Porterville, CA 93257 Phone: 559-788-0452 | |
Andrew David Skorheim, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 26501 Avenue 140 Apt 30, Porterville, CA 93257 Phone: 562-822-1279 | |
Spencer C Pantera, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 53 E Olive Ave, Porterville, CA 93257 Phone: 559-791-9238 | |
Cheng Chang, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 800 N Westwood St, Porterville, CA 93257 Phone: 559-784-2876 | |
Parmbir Singh Kahlon, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1250 W Henderson Ave, Wal-mart Pharmacy, Porterville, CA 93257 Phone: 559-783-8195 | |
Cindy Lee, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1250 W Henderson Ave, Porterville, CA 93257 Phone: 559-783-2090 Fax: 559-783-2092 |